Search Results

The TTC Phantom® Intramedullary Nail system is intended for tibiotalocalcaneal arthrodesis (fusion) and to provide stabilization of the hindfoot and ankle including the transverse tarsal joints coupling the mid-foot to the hindfoot. Examples of specific indications include:

• · Post-traumatic or degenerative arthritis
• · Previously infected arthrosis
• Revision of failed ankle arthrodesis
• · Revision of failed total ankle arthroplasty
• · Talar deficiency conditions such as avascular necrosis of the talus (requiring tibiocalcaneal arthrodesis)
• · Neuromuscular deformity or other neuromuscular disease with severe deformity or instability of the ankle
• · Rheumatoid arthritis
• · Osteoarthritis
• Nonunions or pseudarthrosis of hindfoot and distal tibia
• · Trauma (severe or malunited tibial pilon fracture)
• · Charcot foot (neuroarthropathy)
• · Severe end-stage degenerative arthritis
• · Instability and skeletal defects after tumor resection
• · Pantalar arthrodesis
• · Severe foot/ankle deformity

The Paragon 28® TTC Phantom® Intramedullary Nail System is comprised of intramedullary nails, screws and accessory components. The Phantom® nails are offered in a variety of sizes lengths, and configurations to accommodate variations in patient anatomy. The Phantom® screws insert through the intramedullary nail to secure the construct. These are offered in varying lengths to accommodate the anatomical fixation required.

This document describes a 510(k) premarket notification for the TTC Phantom® Intramedullary Nail System, which is a medical device for tibiotalocalcaneal arthrodesis. It does NOT describe an AI/ML powered device, and therefore the requested information regarding acceptance criteria, study design for AI/ML performance, ground truth establishment, sample sizes for training/test sets, expert involvement, and reader studies is not applicable to this submission.

The document focuses on demonstrating substantial equivalence to predicate devices through:

1. Indications for Use: Listing the specific conditions for which the device is intended.
2. Device Description: Detailing the components of the system.
3. Preclinical Testing: Describing mechanical testing (static and dynamic per ASTM F1264-14), wear testing, and biocompatibility evaluation (per ISO 10993-1 and CDRH's 2016 Biocompatibility Guidance). Additional testing mentioned includes bacterial endotoxins and sterilization.
4. Conclusion: Stating that the device is substantially equivalent to predicates based on intended use, technological characteristics, and preclinical testing.

Therefore, I cannot provide details on AI/ML acceptance criteria or studies from the provided text.

Ask a specific question about this device